Stock listing

BOATS:MBIO Mustang Bio, Inc. Stock

US listing (BOATS) of Mustang Bio, Inc. · home listing NASDAQ:MBIO

Follow Mustang Bio, Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:MBIO

$0.415 USD +0.015 (+3.7%)

Close on Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:MBIO

Past year -70.1% · daily closes, Nov 3, 2025 – Nov 2, 2026, adjusted for splits
Day range
$0.400 – $0.426 USDNov 2, 2026
Volume
34,153 sharesNov 2, 2026
Market cap
$2.79M USDAt the close on Nov 2, 2026 · price × 6.73M shares outstanding
52-week range
$0.350 – $1.450 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
Traded on an average day
$15,070 USDMedian day 25,900 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Mustang Bio, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:MBIO · Home$0.415 USD+0.015 (+3.7%)34,153$0.401$0.426$0.400$0.400Close on Nov 2, 2026

Daily closes

Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:MBIO · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.415+0.015+3.7%$0.401$0.426$0.40034,153
$0.400+0.008+1.9%$0.393$0.427$0.39048,267
$0.393+0.032+9.0%$0.385$0.405$0.37044,654
$0.360+0.001+0.2%$0.352$0.378$0.35124,835
$0.360-0.001-0.2%$0.357$0.385$0.35025,451
$0.360-0.010-2.7%$0.373$0.381$0.36010,244
$0.370+0.001+0.3%$0.390$0.391$0.36217,700
$0.369-0.014-3.7%$0.386$0.402$0.36929,200
$0.383+0.003+0.8%$0.388$0.401$0.37028,600
$0.380+0.007+1.9%$0.370$0.388$0.37010,200
$0.373-0.003-0.8%$0.372$0.385$0.3719,100
$0.376-0.010-2.6%$0.402$0.419$0.37130,000
$0.386+0.016+4.3%$0.370$0.392$0.37031,500
$0.370-0.007-1.9%$0.380$0.427$0.370159,800
$0.377-0.035-8.5%$0.394$0.396$0.37530,000
$0.412+0.012+3.0%$0.410$0.438$0.38154,400
$0.400-0.017-4.1%$0.434$0.434$0.38097,100
$0.417-0.033-7.3%$0.449$0.449$0.410101,100
$0.450-0.010-2.2%$0.456$0.460$0.45017,200
$0.4600.0000.0%$0.460$0.470$0.45543,300
$0.460-0.011-2.3%$0.460$0.466$0.46016,600
$0.471+0.004+0.9%$0.467$0.480$0.46033,400
$0.467+0.004+0.9%$0.468$0.468$0.45916,100
$0.463-0.017-3.5%$0.471$0.475$0.45828,600
$0.480-0.027-5.3%$0.503$0.507$0.47049,200
$0.507-0.013-2.5%$0.511$0.520$0.50412,100
$0.520-0.006-1.1%$0.525$0.525$0.5205,100
$0.526+0.015+2.9%$0.540$0.544$0.50139,000
$0.511-0.020-3.8%$0.487$0.550$0.48724,100
$0.531-0.019-3.5%$0.541$0.554$0.53118,900
$0.550+0.010+1.9%$0.530$0.558$0.53042,300
$0.540+0.050+10.2%$0.490$0.540$0.49052,500
$0.490-0.010-2.0%$0.511$0.511$0.48526,600
$0.500-0.004-0.8%$0.513$0.513$0.46641,800
$0.504-0.006-1.2%$0.545$0.545$0.50441,700
$0.510+0.003+0.6%$0.539$0.539$0.50720,500
$0.507-0.013-2.5%$0.532$0.550$0.50725,900
$0.520-0.008-1.5%$0.540$0.540$0.52020,600
$0.528-0.013-2.4%$0.552$0.552$0.5248,900
$0.541-0.002-0.4%$0.540$0.555$0.53322,500
$0.543-0.017-3.0%$0.553$0.558$0.53237,400
$0.560+0.017+3.1%$0.543$0.561$0.54329,900
$0.543-0.005-0.9%$0.550$0.550$0.54111,600
$0.548+0.010+1.9%$0.540$0.549$0.53718,100
$0.5380.0000.0%$0.538$0.540$0.5339,100
$0.538-0.012-2.2%$0.550$0.550$0.53020,300
$0.550-0.010-1.8%$0.560$0.560$0.54833,200
$0.560+0.008+1.4%$0.545$0.568$0.54515,800
$0.552+0.001+0.2%$0.551$0.577$0.5506,300
$0.551-0.028-4.8%$0.570$0.578$0.55031,800
$0.579+0.006+1.0%$0.573$0.579$0.5706,500
$0.573-0.001-0.2%$0.560$0.573$0.56014,200
$0.574+0.004+0.7%$0.553$0.585$0.55310,100
$0.570-0.024-4.0%$0.580$0.596$0.55216,100
$0.5940.0000.0%$0.594$0.600$0.5948,300
$0.5940.0000.0%$0.587$0.594$0.58711,600
$0.594-0.011-1.8%$0.601$0.602$0.59228,800
$0.605-0.003-0.5%$0.608$0.623$0.59086,100
$0.608+0.018+3.1%$0.580$0.620$0.58021,400
$0.590-0.011-1.8%$0.600$0.619$0.56031,000
$0.601+0.026+4.5%$0.561$0.653$0.56174,300
$0.575-0.022-3.7%$0.530$0.610$0.53010,400
$0.597+0.003+0.5%$0.590$0.600$0.5906,700
$0.594+0.017+2.9%$0.563$0.602$0.55727,500
$0.577+0.007+1.2%$0.599$0.599$0.55072,400
Ticker
BOATS:MBIO
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
BOATS
Currency
USD

Latest news

Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101 (IL13Ra2-targeted CAR T-cells) to Treat Astrocytomas and Glioblastoma

Jul 7, 2025

Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement

Mar 5, 2025

Mustang Bio Announces Sale of Fixed Assets and Exit of Facility

Feb 27, 2025

Mustang Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement

Feb 11, 2025

Mustang Bio Announces Closing of $8 Million Public Offering

Feb 10, 2025

Mustang Bio Announces Pricing of $8 Million Public Offering

Feb 6, 2025

Mustang Bio Announces Reverse Stock Split

Jan 14, 2025

Mustang Bio Receives Positive Listing Determination from Nasdaq

Nov 12, 2024

Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant Glioma

Nov 7, 2024

Mustang Bio Announces Exercise of Warrants for $4 Million Gross Proceeds Form 8 K

Oct 24, 2024

All Mustang Bio, Inc. news

Decks

Mustang Bio, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
123 in all · newest Jul 7, 2025 · oldest 2019
Decks
3 decks · latest February 2024

Where Mustang Bio, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:MBIO · Home listingNASDAQUnited StatesUSD
BOATS:MBIO · This pageBOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about Mustang Bio, Inc.